Author

Joerg Schuettrumpf

Observed names: J. Schuettrumpf, Joerge Schuettrumpf

Observed institutions: Goethe University Frankfurt, Children's Hospital of Philadelphia, Howard Hughes Medical Institute, German Red Cross, Biotest (Germany), Grifols (Spain), University of Pennsylvania

ORCID: 0000-0002-8855-4096

Observed ORCID: 0000-0002-8855-4096

OpenAlex ID: A5068778977

A Novel Method of Regional Intravenous Delivery of AAV Vector to Skeletal Muscle Results in Correction of Canine Hemophilia B Phenotype.

2004 · Valder R. Arruda, Hansell H. Stedman, et al. · Blood · 6

Changing educational paradigms in transfusion medicine

2011 · E. Seifried, J. Schuettrumpf, et al. · ISBT Science Series · 4

Efficacy and safety of prophylaxis and treatment of bleeding events with a novel fibrinogen concentrate from human plasma in patients with congenital fibrinogen deficiency

2026 · Claudia Djambas Khayat, Amal El-Beshlawy, et al. · Thrombosis Research · 2

PDF

Pharmacokinetics, Hemostatic Efficacy, and Safety of a New Human Fibrinogen Concentrate in Adult and Pediatric Patients with Congenital Fibrinogen Deficiency

2025 · Claudia Djambas Khayat, Amal El-Beshlawy, et al. · Thrombosis and Haemostasis · 2

PDF

Evaluation of Pharmacokinetics, Efficacy and Safety of a New Human Fibrinogen Concentrate in Patients with Congenital Fibrinogen Deficiency

2024 · Claudia Djambas Khayat, Heike Boehm, et al. · Blood · 1

PDF

Corrigendum to “Inadvertent Germline Transmission of AAV2 Vector: Findings in a Rabbit Model Correlate with Those in a Human Clinical Trial”

2006 · Joerg Schuettrumpf, Jian-Hua Liu, et al. · Molecular Therapy · 1

Differences in the Anticoagulant Activity of Murine and Human Activated Protein C (APC) in Mouse Thrombosis Models.

2006 · Christian Furlan Freguia, Joerg Schuettrumpf, et al. · Blood · 1

Assessing the Role of Continuous Activated Protein C (APC) Expression in Murine Thrombosis Models.

2005 · Joerg Schuettrumpf, Alexander Schlachterman, et al. · Blood · 1

A Novel Role of Coagulation Proteases on Viral-Based Gene Transfer Efficacy.

2004 · Joerg Schuettrumpf, Jianxiang Zou, et al. · Blood · 1

Corrigendum to “Efficacy and safety of prophylaxis and treatment of bleeding events with a novel fibrinogen concentrate from human plasma in patients with congenital fibrinogen deficiency” [Thromb. Res. volume 259 (2026) https://doi.org/10.1016/j.thromres.2026.109616]

2026 · Claudia Djambas Khayat, Amal El-Beshlawy, et al. · Thrombosis Research

PDF

HTRS2025.P1.19 A New Fibrinogen Concentrate for Congenital Fibrinogen Deficiency: Pharmacokinetic Parameters and Efficacy

2025 · Wolfgang Miesbach, Claudia Djambas Khayat, et al. · Research and Practice in Thrombosis and Haemostasis

Mesenchymal Stromal Cells Suppress T-and B-Cells via Galectin-9 in a Donor Dependent Manner

2012 · Christopher Ungerer, Patricia Quade-Lyssy, et al. · Blood

In Vivo Effects of Murine and Human APC

2007 · C. Furlan Freguia, J. Schuettrumpf, et al. · Journal of Thrombosis and Haemostasis

Protease−Activated Receptor 2 (PAR−2) as a Novel Target To Prevent Inhibitor Formation to FIX.

2006 · Stefano Baila, Christian Furlan Freguia, et al. · Blood

75. Protease-Activated Receptor 2 as a Novel Target for Immune Modulation for AAV-Mediated Gene Transfer to Skeletal Muscle

2006 · Stefano Baila, Christian Furlan Freguia, et al. · Molecular Therapy

879. Effects of Continuous Expression of Activated Protein C (APC) in Novel Murine Thrombosis Models

2006 · Christian Furlan Freguia, Joerg Schuettrumpf, et al. · Molecular Therapy

PDF

Co-Inheritance of FV Leiden and High Levels of FIX Results in Novel Models for Thrombophilia and Spontaneous Fetal Loss.

2005 · Christian Furlan Freguia, Joerg Schuettrumpf, et al. · Blood

Protease-Activated Receptor-2 (PAR-2) as a Novel Target for Modulating Immune Responses to Neo Antigens Following In Vivo Gene Transfer.

2005 · Stefano Baila, Christian Furlan Freguia, et al. · Blood

Works count: 18

Citation count: 19

H-index: 2

I10-index: